NCI Awards ADA $150K to Develop Nanotech Biomarker-Discovery Platform | GenomeWeb
NEW YORK (GenomeWeb News) - ADA Technologies said today that it has received a $149,121 grant from the National Cancer Institute to develop a nanotechnology-based imaging and sensing platform for discovering cancer biomarkers.
 
ADA said it is developing a sensing platform for analyzing biomolecules, such as cancer biomarkers, “that is more sensitive than existing technologies,” but did not disclose further details of the technology.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.